TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12118642

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (50 microg)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Oral misoprostol (100 microg)
Number of subjects: 250
Study: 10518976

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (5 x 3.3 Gy, 9 MeV photons)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (no preoperative irradiation)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Postoperative irradiation (if risk factors present)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Pre- and postoperatively irradiated patients with risk factors
Number of subjects: 94
Study: 7733345

Group type: EXPERIMENTAL
Intervention: Atropine (0.04 mg/kg i.v.)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Propranolol (0.2 mg/kg i.v.)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Double autonomic blockade (Atropine + Propranolol)
Number of subjects: 39
Study: 2252732

Group type: EXPERIMENTAL
Intervention: Midline insertion site with straight intraperitoneal segment catheter
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Lateral rectus muscle insertion site with spiral intraperitoneal segment catheter
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Overall catheter complications
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Late catheter removals due to peritonitis episodes
Number of subjects: 85
Study: 7214807

Group type: EXPERIMENTAL
Intervention: 6 g fractionated dose of iopanoic acid (Telepaque)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sodium ipodate (Biloptin)
Number of subjects: 100
Study: 31291276

Group type: EXPERIMENTAL
Intervention: High self-involvement condition
Number of subjects: 118

Group type: COMPARATOR
Intervention: Low self-involvement condition
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Older adults
Number of subjects: 118

Group type: COMPARATOR
Intervention: Young adults
Number of subjects: 118
Study: 28980579

Group type: EXPERIMENTAL
Intervention: Neuropsychological computer programs
Number of subjects: 68

Group type: COMPARATOR
Intervention: Entertainment computer games
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 68
Study: 26034931

Group type: EXPERIMENTAL
Intervention: 400 mg of moxifloxacin per os once daily for 7 days
Number of subjects: 39

Group type: COMPARATOR
Intervention: 500 mg of metronidazole and 500 mg amoxicillin per os three times daily for 7 days
Number of subjects: 39
Study: 23118430

Group type: EXPERIMENTAL
Intervention: Tadalafil 10 mg
Number of subjects: 16
Study: 21645573

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccination (7vPCV) at birth, 1 and 2 months
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccination (7vPCV) at 1, 2 and 3 months
Number of subjects: 318

Group type: COMPARATOR
Intervention: 7-valent pneumococcal conjugate vaccination (7vPCV) at birth
Number of subjects: 318

Group type: COMPARATOR
Intervention: Control group (no vaccination)
Number of subjects: 318
Study: 18795905

Group type: EXPERIMENTAL
Intervention: Web-based consultations (remote dermatology consultations through a secure web-based communication system)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Traditional treatment (general practitioner visits and hospital care)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Web-based consultations
Number of subjects: 98
Study: 17334508

Group type: EXPERIMENTAL
Intervention: Self-management group (SMG)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Routine care group (RCG)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 195
Study: 12671775

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy provided at different study centers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower baseline viral load, lower nonnucleoside reverse transcriptase inhibitor resistance, lower protease inhibitor resistance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Study sites divided into two groups based on Week 12 HIV RNA values
Number of subjects: 0
Study: 10993428

Group type: EXPERIMENTAL
Intervention: Pantoprazole (Pan) 80 mg O.D. for 1 week with clarithromycin (Cla) 500 mg B.I.D. and amoxicillin (Amo) 1 g B.I.D. for 5 days
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Omeprazole (Ome) 40 mg O.D. for 1 week with clarithromycin (Cla) 500 mg B.I.D. and amoxicillin (Amo) 1 g B.I.D. for 5 days
Number of subjects: 172
Study: 9195642

Group type: EXPERIMENTAL
Intervention: Psychosocial nursing intervention (weekly postoperative telephone follow-up, evaluation and counseling by a psychiatric liaison nurse, participation in an ICD support group)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual postoperative care and follow-up (control group)
Number of subjects: 34
Study: 1603539

Group type: EXPERIMENTAL
Intervention: Sub‐tenon's injections of methylprednisolone acetate (20 mg) along with topical 1% prednisolone acetate and 1% atropine
Number of subjects: 3
Study: 3890818

Group type: EXPERIMENTAL
Intervention: Netilmicin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cefoperazone
Number of subjects: 32
Study: 31167872

Group type: EXPERIMENTAL
Intervention: SMART cognitive training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 60
Study: 30547822

Group type: EXPERIMENTAL
Intervention: Cultivars of banana and plantain; 87 locally recognized cultivars identified: 73 banana and 14 plantain.
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Production constraints identified; main biotic challenges: banana weevil (Cosmopolites sordidus) and banana bunchy top virus (BBTV); abiotic problems: drought and wind.
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Local varieties; some local varieties like Amandan, Assonwonnou, Coleti, and Ninkouin are extremely rare.
Number of subjects: 51
Study: 26503737

Group type: EXPERIMENTAL
Intervention: Calcium phosphate (Ca2) with probiotic (Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Calcium carbonate (Ca1) with probiotic
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Probiotic alone
Number of subjects: 32

Group type: COMPARATOR
Intervention: Calcium phosphate (Ca2)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Calcium carbonate (Ca1)
Number of subjects: 32
Study: 24387872

Group type: EXPERIMENTAL
Intervention: High-frequency chest wall oscillation (HFCWO)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Chest physiotherapy (CPT)
Number of subjects: 45
Study: 22348910

Group type: EXPERIMENTAL
Intervention: Standard antifungal treatment plus pessary capsules containing 200 mg GMH (twice a week for thirty days)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard antifungal treatment
Number of subjects: 26
Study: 20102847

Group type: EXPERIMENTAL
Intervention: Whole-grain RTE oat cereal (3 g/day oat b‐glucan)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control (energy-matched low-fiber foods)
Number of subjects: 204
Study: 19253862

Group type: EXPERIMENTAL
Intervention: Ocimum sanctum leaf extract (500 mg/capsule, twice daily, p.o. after meal)
Number of subjects: 35
Study: 16433396

Group type: EXPERIMENTAL
Intervention: AElite Fil
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: AElite Flo
Number of subjects: 15

Group type: COMPARATOR
Intervention: Both materials
Number of subjects: 15
Study: 12598502

Group type: EXPERIMENTAL
Intervention: Mild hypothermia at 34 degrees C for the first 12 hours of ECMO
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mild hypothermia at 35 degrees C for the first 12 hours of ECMO
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mild hypothermia at 36 degrees C for the first 12 hours of ECMO
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group at 37 degrees C
Number of subjects: 20
Study: 10100104

Group type: EXPERIMENTAL
Intervention: Eprosartan 400-800 mg once a day
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Eprosartan 200-400 mg twice a day
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study: 8777120

Group type: EXPERIMENTAL
Intervention: Clonidine 120 micrograms with fentanyl 50 micrograms
Number of subjects: 28

Group type: COMPARATOR
Intervention: 0.25% bupivacaine (25 mg)
Number of subjects: 28
Study: 1856404

Group type: EXPERIMENTAL
Intervention: Aspirin and dipyridamole
Number of subjects: 247

Group type: COMPARATOR
Intervention: Not applicable (placebo)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Clinical characteristics (severity of angina)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Anatomic characteristics (percent diameter stenosis before angioplasty, stenosis greater than 10 mm in length, calcific stenosis)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Residual percent diameter stenosis and residual mean pressure gradient
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Length of stenosis and residual percent diameter stenosis
Number of subjects: 247
Study: 6668409

Group type: EXPERIMENTAL
Intervention: PGF2 alpha gel 5 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: PGF2 alpha gel 2.5 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 29616398

Group type: EXPERIMENTAL
Intervention: Automatic spectral imaging protocol selection (ASIS) plus 50% adaptive statistical iterative reconstruction (ASIR)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group with 120 kVp voltage
Number of subjects: 64
Study: 27521979

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200mg twice daily for eight weeks
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 24937019

Group type: EXPERIMENTAL
Intervention: Qualitative research conducted concurrently with RCTs
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Feedback of interim or final qualitative findings to trial team members
Number of subjects: 15
Study: 22490878

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 31350

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 31350

Group type: COMPARATOR
Intervention: Lisinopril
Number of subjects: 31350

Group type: EXPERIMENTAL
Intervention: Chlorthalidone, Amlodipine, Lisinopril
Number of subjects: 31350
Study: 20469573

Group type: EXPERIMENTAL
Intervention: Pelvic floor re-education intervention
Number of subjects: 0
Study: 18381952

Group type: EXPERIMENTAL
Intervention: Psychosocial telephone counseling (PTC) intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study: 16060200

Group type: EXPERIMENTAL
Intervention: Homeopathy
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Fluoxetine (Prozac)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Primary outcome measures
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Adverse drug reactions, clinical global impression (CGI), HAMD, mini international psychiatric Interview, Pittsburgh sleep quality index, Side‐effects checklist, Short Form 12, treatment credibility questionnaire, work and social disability scale
Number of subjects: 11
Study: 12021004

Group type: EXPERIMENTAL
Intervention: Ultrasonic motion analysis system
Number of subjects: 4
Study: 10407522

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg and midazolam 0.05 mg/kg (group I)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg and midazolam 0.1 mg/kg (group II)
Number of subjects: 60
Study: 8773212

Group type: EXPERIMENTAL
Intervention: maprotiline (n = 15)
Number of subjects: 33

Group type: COMPARATOR
Intervention: fluvoxamine (n = 18)
Number of subjects: 33
Study: 2343795

Group type: EXPERIMENTAL
Intervention: Assertiveness Training with Behavioral Practice (ATBP)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Assertiveness Training with Journal (ATJ)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Waiting List Control (WLC)
Number of subjects: 43
Study: 7380107

Group type: EXPERIMENTAL
Intervention: Diet regulation and 0.5 g tolbutamide t.i.d. (N = 49)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Diet regulation and one placebo tablet t.i.d. (N = 48)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Diet regulation only (N = 50)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: No treatment (N = 61)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: No treatment, OGTT at follow-up (N = 59)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Normal OGTT control group (N = 52)
Number of subjects: 267
Study: 30710769

Group type: EXPERIMENTAL
Intervention: Aging only
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Aging then freezing/thawing
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Freezing then thaw/aging
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Freezing treatments (both aging then freezing/thawing and freezing then thaw/aging)
Number of subjects: 10
Study: 28658329

Group type: EXPERIMENTAL
Intervention: Non-adherent Ibuprofen foam dressing (IFD)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Primary dressing (Control Group)
Number of subjects: 80
Study: 24921163

Group type: EXPERIMENTAL
Intervention: Women with PCOS
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparison group of overweight women without PCOS
Number of subjects: 18
Study: 23580597

Group type: EXPERIMENTAL
Intervention: Endurance exercise for 60 min at 60‐65% aerobic capacity (E)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: High‐intensity resistance exercise for 60 min (R)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Sedentary control trial (C)
Number of subjects: 3
Study: 21419411

Group type: EXPERIMENTAL
Intervention: SAFE or SORRY? programme
Number of subjects: 2593

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2593
Study: 19732495

Group type: EXPERIMENTAL
Intervention: Tinidazole 1 g
Number of subjects: 50
Study: 17356086

Group type: EXPERIMENTAL
Intervention: Sleep laboratory RP (LRP)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Home RP (HRP)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Home RP (HRP) using total recording time (RDITRT)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Interobserver reliability for LRP and HRP
Number of subjects: 62
Study: 15142199

Group type: EXPERIMENTAL
Intervention: Rabeprazole (Proton-pump inhibitor) for 4 weeks
Number of subjects: 232

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 232
Study: 11465668

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 399

Group type: COMPARATOR
Intervention: Control (unvaccinated)
Number of subjects: 399
Study: 10861309

Group type: EXPERIMENTAL
Intervention: Retinyl palmitate (300000 IU daily for 1 year followed by 150000 IU for a 2nd year)
Number of subjects: 2592

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (600 mg daily for 2 years)
Number of subjects: 2592

Group type: EXPERIMENTAL
Intervention: Both retinyl palmitate and N-acetylcysteine
Number of subjects: 2592

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 2592
Study: 9188924

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Inhaled cromoglycate
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Methacholine reactivity measurement
Number of subjects: 19
Study: 1366257

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg o.d.
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg o.d.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (during run-in period)
Number of subjects: 58
Study: 3933619

Group type: EXPERIMENTAL
Intervention: CR3 retinal camera
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CR2 retinal camera
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ophthalmoscopy (control)
Number of subjects: 0
Study: 30328495

Group type: EXPERIMENTAL
Intervention: Nontourniquet group
Number of subjects: 81

Group type: COMPARATOR
Intervention: Tourniquet group
Number of subjects: 81
Study: 29505381

Group type: EXPERIMENTAL
Intervention: Conditional cash transfers (Family Rewards)
Number of subjects: 2377

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2377
Study: 27091348

Group type: EXPERIMENTAL
Intervention: Online communication tool for patients
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Affective communication behaviour of the health care professional
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Information exchange
Number of subjects: 78
Study: 23893503

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT)
Number of subjects: 134
Study: 22385030

Group type: EXPERIMENTAL
Intervention: Post-shave moisturizers containing glycerine and emollients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incorporation of specific ingredients such as niacinamide
Number of subjects: 0
Study: 20523287

Group type: EXPERIMENTAL
Intervention: Early control of the distal internal carotid artery (group A, N=12)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Traditional CEA with dissection of the total carotid bifurcation (group B, N=17)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 28
Study: 17629731

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 44
Study: 16188771

Group type: EXPERIMENTAL
Intervention: Maternal milk protein intake from cheese during pregnancy
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Maternal consumption of raw milk products during lactation
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Maternal cheese consumption
Number of subjects: 112
Study: 11919120

Group type: EXPERIMENTAL
Intervention: High-Protein (HP) diet (28% protein, 42% carbohydrate)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low-Protein (LP) diet (16% protein, 55% carbohydrate)
Number of subjects: 26
Study: 10639847

Group type: EXPERIMENTAL
Intervention: Ivermectin (6 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 8521296

Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 2290135

Group type: EXPERIMENTAL
Intervention: Aerobic exercise for 13 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-aerobic control
Number of subjects: 0
Study: 31550844

Group type: EXPERIMENTAL
Intervention: GEDI-guided fluid resuscitation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Early goal-directed therapy
Number of subjects: 41
Study: 27153360

Group type: EXPERIMENTAL
Intervention: Fulranumab 1 mg (1 mgQ4 wk)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Fulranumab 3 mg (3 mgQ4 wk)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Fulranumab 10 mg (10 mgQ4 wk)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 25826143

Group type: EXPERIMENTAL
Intervention: Pomegranate extract (1000 mg capsule, 7 days/week for 6 months)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (noncaloric capsule, 7 days/week for 6 months)
Number of subjects: 33
Study: 24079625

Group type: EXPERIMENTAL
Intervention: Gomco circumcision clamp plus tissue adhesive
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional open surgical circumcision with suturing
Number of subjects: 200
Study: 21857908

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention aimed at social bonding
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (non-participants)
Number of subjects: 100
Study: 19213793

Group type: EXPERIMENTAL
Intervention: UK-500,001 1.0 mg b.i.d.
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: UK-500,001 0.1 mg b.i.d.
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: UK-500,001 0.4 mg b.i.d.
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study: 17227996

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1200 mg of elemental calcium daily for 4 years)
Number of subjects: 930

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 930
Study: 15472179

Group type: EXPERIMENTAL
Intervention: Alendronate (2.5 mg daily)
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: Alendronate (5 mg daily)
Number of subjects: 585

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 585
Study: 11558856

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg, once daily)
Number of subjects: 495

Group type: COMPARATOR
Intervention: Valsartan (80 mg, once daily)
Number of subjects: 495
Study: 9499281

Group type: EXPERIMENTAL
Intervention: Cefoxitin (100 mg/kg/24 h)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Ceftizoxime (100 mg/kg/24 h)
Number of subjects: 288
Study: 7871233

Group type: EXPERIMENTAL
Intervention: Preworkshift meeting reviewing five randomly selected interactions recorded during the previous day's shift, including self-evaluation, praise, corrective feedback, and role-play.
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Review of tape-recorded interactions prior to randomly selected shifts (for Dana) and supplemented with graphic feedback (for Rick).
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: No tape recorder worn during the second observation period.
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Final phase without tape recorder and follow-up observations 4 to 8 weeks later.
Number of subjects: 2
Study: 3048373

Group type: EXPERIMENTAL
Intervention: High energy supplementation (1.95 MJ or 465 kcal per day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low energy supplementation (218 kJ or 52 kcal per day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (baseline home diet average 6.28 MJ or 1500 kcal)
Number of subjects: 0
Study: 31787434

Group type: EXPERIMENTAL
Intervention: Epiaortic ultrasound performed by the surgeon using a high frequency (>7 MHz) ultrasound transducer.
Number of subjects: 1150

Group type: COMPARATOR
Intervention: No epiaortic ultrasound performed (Control group).
Number of subjects: 1150
Study: 31269876

Group type: EXPERIMENTAL
Intervention: Monoblock polyethylene design (Group A)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Modular polyethylene design (Group B)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Comparison between Monoblock and Modular designs
Number of subjects: 53

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 53